Glaxo Group Limited

Paul Martin Gore

Simon Teanby Hodgson

Diane Mary Coe

Panayiotis Alexandrou Procopiou

Brian Edgar Looker

Duncan B Judd

Lee Andrew Harrison

Suzanne Elaine Keeling

Anthony William James Cooper

Colin David Eldred

Stephen Swanson

Xiao Qing Lewell

David House

Caroline Mary Cook

Graeme Michael Robertson

Sadie Vile

Rachael Anne Ancliff

Stefan Senger

David George Allen

Ashley Paul Hancock

Steven Leslie Sollis

Leanda Jane Kindon

Mark Wilkinson

Andrew John Walker

Rachael Ann Ancliff

Gail Mills

Martin Alistair Hayes

Caroline Wilson

Michael Joachim Kranz

Duncan Bruce Judd

The present invention relates to a pyrazole amide derivative, pharmaceutical compositions containing this compound and to its use in therapy.

Pyrazole compounds acting against allergic, immune and inflammatory conditions

The present invention relates to pyrazole amide derivatives pharmaceutical compositions containing these compounds and to their use in therapy.

Pyrazole compounds acting against allergic, inflammatory and immune disorders

The present invention relates to amide compounds, processes for their preparation, pharmaceutical compositions containing these compounds and to their use in the treatment of disorders, conditions or disorders such as allergic disorders, inflammatory disorders and disorders of the immune system.

N-pyrazolyl carboxamides as CRAC channel inhibitors

The present invention relates to a compound which is N-(4-{4-[(6-butyl-8-quinolinyl)oxy]-1-piperidinyl}butyl)ethanesulfonamide and salts thereof, processes for its preparation, to compositions containing it and to its use in the treatment of various diseases, such as allergic rhinitis.

Compounds

Morpholinyl-urea derivatives for use in the treatment of inflammatory diseases

There are provided according to the invention, novel compounds of formula (I) wherein R, R, R, R, R, R, X, a, b and Z are as defined in the specification, processes for preparing them, formulations containing them and their use in therapy for the treatment of inflammatory diseases.

Compounds useful in the treatment of inflammatory diseases

The present invention relates to novel morpholin-acetamide compounds of formula (I) useful for the treatment of inflammatory diseases. Compounds of formula (I)wherein R, R, R, R, R, X, a, b and Z are as defined in the specification, processes for preparing them, formulations containing them and their use in therapy for the treatment of inflammatory diseases.

Morpholin-acetamide derivatives for the treatment of inflammatory diseases

Growing community of inventors

Stevenage, United Kingdom

Paul Martin Gore